Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 409
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03697850 | Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy | ||
| NCT00957866 | Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity | ||
| NCT03224208 | Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients | ||
| NCT01048879 | Pharmacokinetics of Tamiflu® (Oseltamivir) in Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)and or Continuous Venovenous Hemodialysis (CVVHD) | ||
| NCT03767075 | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) | ||
| NCT02622581 | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | ||
| NCT00223301 | Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis | ||
| NCT00815867 | Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant | ||
| NCT00476164 | Study of Rituximab to Treat Chronic Renal Transplant Rejection | ||
| NCT02012634 | Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer | ||
| NCT03385668 | Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies | ||
| NCT03455582 | Cognition Evolution and MRI Markers in PPMS Patients on 2 Years | ||
| NCT01329952 | Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment | ||
| NCT04405349 | Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer | ||
| NCT00170170 | Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation | ||
| NCT00396435 | Correction of Anaemia and Progression of Renal Failure on Transplanted Patients | ||
| NCT06191068 | Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia | ||
| NCT01428414 | Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer | ||
| NCT00719264 | Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer | ||
| NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | ||
| NCT00203606 | Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C | ||
| NCT03526601 | Screening Of Adult urBan pOpulation To diAgnose Heart Failure | ||
| NCT03590535 | 5th Generation cTnT in ED ACS | ||
| NCT00127036 | Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) | ||
| NCT04641676 | A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center | ||
| NCT00405860 | CellCept in p-ANCA Vasculitis | ||
| NCT03498625 | Crohn's Disease Endoscopic REmission Definition in an Objective Way | ||
| NCT00738829 | Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL | ||
| NCT03691077 | Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 | ||
| NCT01384838 | Exercise Training in Postmenopausal Patients With Breast Cancer | ||
| NCT04335071 | Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) | ||
| NCT04702256 | Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF | ||
| NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | ||
| NCT04808245 | A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas | ||
| NCT05008081 | The CATALINA Study | ||
| NCT01847677 | Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin | ||
| NCT00427375 | Local Excision in Downstaged Rectal Cancer | ||
| NCT00963534 | Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma. | ||
| NCT00144976 | Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma | ||
| NCT05118724 | Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin | ||
| NCT07670117 | HAIQU (Hospital AIr QUality) | ||
| NCT03721484 | CINtec PLUS Triage in HPV Primary Screening | ||
| NCT01457144 | Study of Mantle Cell Lymphoma Treatment by RiBVD | ||
| NCT04671693 | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. | ||
| NCT01321957 | Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal Cancer | ||
| NCT05975242 | Acceptability & Impact of a Diabetes Management Smartphone App (mySugr) for Spanish-literate Adults With Type 2 Diabetes | ||
| NCT01350882 | Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation | ||
| NCT01661790 | Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer | ||
| NCT00875979 | A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab | ||
| NCT01326559 | Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) |
